Showing results (1201-1210 of 1,380) with videos related to
Sort By:
Pageof 138
Scientific Reports|November 25, 2020
The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acidsNidhi M Sagar, Henri Duboc, Gemma L Kay, et al.Ocular Oncology and Pathology|January 27, 2022
Analytical Validation and Performance of a 7-Gene Next-Generation Sequencing Panel in Uveal MelanomaKatherina M Alsina, Lauren M Sholl, Kyle R Covington, et al.Melanoma Research|March 7, 2022
Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition StagingOliver J Wisco, Justin W Marson, Graham H Litchman, et al.Open Forum Infectious Diseases|November 8, 2022
Discriminatory Ability of Gas Chromatography-Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict PrognosisJoshua Nazareth, Daniel Pan, Jee Whang Kim, et al.Journal of Clinical Apheresis|June 23, 2026
Chronic Red Cell Exchange for the Management of Alpha Thalassemia Major Complicated by Iron OverloadDaniel Y Chang, Sanjana B Shah, Arielle Langer, et al.Frontiers in Public Health|November 15, 2021
Adding a Seat at the Table: A Case Study of the Provider's Perspective on Integrating Community Health Workers at Provider Practices in CaliforniaCourtney A Paulson, Eva M Durazo, Leigh D Purry, et al.Pain Medicine (Malden, Mass.)|January 29, 2019
Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel ReportKurt Kroenke, Daniel P Alford, Charles Argoff, et al.Iscience|September 12, 2024
Utility, feasibility, and socio-demographic considerations in the diagnosis of bacterial RTI's by GC-IMS breath analysisTrenton K Stewart, Emma Brodrick, Matthew J Reed, et al.Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitorsJames J-W Duan, Lihua Chen, Zhonghui Lu, et al.Pharmacogenetics and Genomics|February 17, 2025
Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosisNia Covington, Anne F Luetkemeyer, Marjorie Z Imperial, et al.Pageof 138